Deslorelin

DB11510InvestigationalVet approvedSmall molecule

Deslorelin acetate is an injectable gonadotropin releasing hormone super-agonist also known as an LHRH agonist. It stops the production of sex hormones.

Mechanism: Pharmacologically active on Gonadotropin-releasing hormone receptor
Curator reviewed
Formula / weight: C₆₄H₈₃N₁₇O₁₂ · 1282.475 g/mol (avg)
Code names: H 4065

Resolves to

Compound

UNIITKG3I66TVECAS57773-65-6ChEMBLCHEMBL2365665

Clinical / RWD

RxNorm1311744

Structure

InChIKeyGJKXGJCSJWBJEZ-XRSSZCMZSA-NSMILES

[H][C@]1(CCC(=O)N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC

Targets

P30968GNRHR

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

15+ReferencesStructured and connected to the statements they support

Which drugs share a target with Deslorelin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account